Axsome Therapeutics (AXSM) Q2 2023 Earnings Call Transcript

AXSM earnings call for the period ending June 30, 2023.

Related Keywords

United States , American , Nick Pizzie , Joseph Thome , William Blair , Lori Englebert , Matt Kaplan , Herriot Tabuteau , Joon Lee , Charles Duncan , Vikram Purohit Morgan Stanley , Ram Selvaraju , Jason Gerberry , Marc Goodman , Myles Minter William Blair , Vikram Purohit , Yatin Suneja Guggenheim , Charles Duncan Cantor Fitzgerald , David Amsellem , Myles Minter , Piper Sandler , David Amsellem Piper Sandler , America Merrill Lynch , Yatin Suneja , Graig Suvannavejh , Matt Kaplan Ladenburg Thalmann , Mark Jacobson , Graig Suvannavejh Mizuho , Joon Lee Truist , Exchange Commission , Jason Gerberry Bank , Morgan Stanley , Ladenburg Thalmann , Cantor Fitzgerald , International Sunosi , Company Analyst , Business Development , Axsome Therapeutics , Motley Fool Stock Advisor , Stock Advisor , Axsome Therapeutic , Vice President , Executive Vice President , Truist Securities , Guggenheim Partners ,